(Circulation. 2001;103:2903.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
Transdermal Estrogen Replacement Therapy Decreases Sympathetic Activity in Postmenopausal Women
From the Division of Hypertension and the Donald W. Reynolds Cardiovascular Clinical Research Center, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas.
Correspondence to Wanpen Vongpatanasin, MD, Divisions of Hypertension and Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, J4.134, Dallas, TX 75235-8586. E-mail wanpen.vongpatanasin{at}utsouthwestern.edu
Background—Menopause heralds a dramatic increase in incident hypertension, suggesting a protective effect of estrogen on blood pressure (BP). In female rats, estrogen has been shown to decrease sympathetic nerve discharge (SND) and BP. SND, however, has not been recorded during estrogen replacement therapy (ERT) in humans.
Methods and Results—In 12 normotensive postmenopausal women, we conducted a randomized crossover placebo-controlled study to test whether chronic ERT caused a sustained decrease in SND and BP. Twenty-four-hour ambulatory BP, SND, and arterial baroreflex sensitivity were measured before and after 8 weeks of transdermal estradiol (200 µg/d), oral conjugated estrogens (0.625 mg/d), or placebo. To test the acute effects of estrogen on SND, additional studies were performed in the same women receiving intravenous conjugated estrogens or sublingual estradiol. After 8 weeks of transdermal ERT, the basal rate of SND decreased by 30% (from 40±4 to 27±4 bursts per minute, P=0.0001) and ambulatory diastolic BP fell by 5±2 mm Hg (P=0.0003). In contrast, SND and BP were unaffected either by 8 weeks of oral ERT or by acute estrogen administration. Neither transdermal nor oral ERT had any effects on baroreflex sensitivity.
Conclusions—In normotensive postmenopausal women, chronic transdermal ERT decreases SND without augmenting arterial baroreflexes and causes a small but statistically significant decrease in ambulatory BP. Sympathetic inhibition is evident only with chronic rather than acute estrogen administration, implying a genomic mechanism of action. Because the effects of transdermal ERT are larger than those of oral ERT, the route of administration may be an important consideration in optimizing the beneficial effects of ERT on BP and overall cardiovascular health.
Key Words: hormones • nervous system, sympathetic • blood pressure • menopause
This article has been cited by other articles:
 |
|
 |
|
  M. Barton and M. R. Meyer Postmenopausal Hypertension: Mechanisms and Therapy Hypertension, July 1, 2009; 54(1): 11 - 18. [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Fu, K. Okazaki, S. Shibata, R. P. Shook, T. B. VanGunday, M. M. Galbreath, M. F. Reelick, and B. D. Levine Menstrual cycle effects on sympathetic neural responses to upright tilt J. Physiol., May 1, 2009; 587(9): 2019 - 2031. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Oneda, C. L. M. Forjaz, F. R. Bernardo, T. G. Araujo, J. L. Gusmao, E. Labes, S. B. Abrahao, D. Mion Jr., A. M. Fonseca, and T. Tinucci Low-dose estrogen therapy does not change postexercise hypotension, sympathetic nerve activity reduction, and vasodilation in healthy postmenopausal women Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1802 - H1808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M. Miller and S. P. Duckles Vascular Actions of Estrogens: Functional Implications Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Lawrence, C. A. Ray, and J. R. Carter Vestibulosympathetic reflex during the early follicular and midluteal phases of the menstrual cycle Am J Physiol Endocrinol Metab, June 1, 2008; 294(6): E1046 - E1050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Carter and J. E. Lawrence Effects of the menstrual cycle on sympathetic neural responses to mental stress in humans J. Physiol., December 1, 2007; 585(2): 635 - 641. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gingerich and T. L. Krukoff Estrogen in the Paraventricular Nucleus Attenuates L-Glutamate-Induced Increases in Mean Arterial Pressure Through Estrogen Receptor {beta} and NO Hypertension, December 1, 2006; 48(6): 1130 - 1136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ito, Y. Hirooka, Y. Kimura, Y. Sagara, and K. Sunagawa Ovariectomy Augments Hypertension Through Rho-Kinase Activation in the Brain Stem in Female Spontaneously Hypertensive Rats Hypertension, October 1, 2006; 48(4): 651 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A. Arenas, S. J. Armstrong, Y. Xu, and S. T. Davidge Tumor Necrosis Factor-{alpha} and Vascular Angiotensin II in Estrogen-Deficient Rats Hypertension, September 1, 2006; 48(3): 497 - 503. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Harvey, B. L. Morris, J. A. Miller, and J. S. Floras Estradiol Induces Discordant Angiotensin and Blood Pressure Responses to Orthostasis in Healthy Postmenopausal Women Hypertension, March 1, 2005; 45(3): 399 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J Fadel, Z. Wang, H. Watanabe, D. Arbique, W. Vongpatanasin, and G. D Thomas Augmented sympathetic vasoconstriction in exercising forearms of postmenopausal women is reversed by oestrogen therapy J. Physiol., December 15, 2004; 561(3): 893 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Dubey, B. Imthurn, L. C. Zacharia, and E. K. Jackson Hormone Replacement Therapy and Cardiovascular Disease: What Went Wrong and Where Do We Go From Here? Hypertension, December 1, 2004; 44(6): 789 - 795. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Tung, A. Kopelnik, N. Banki, K. Ong, N. Ko, M. T. Lawton, D. Gress, B. Drew, E. Foster, W. Parmley, et al. Predictors of Neurocardiogenic Injury After Subarachnoid Hemorrhage Stroke, February 1, 2004; 35(2): 548 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Liu, T. B. J. Kuo, and C. C. H. Yang Effects of estrogen on gender-related autonomic differences in humans Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H2188 - H2193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Filippatos and J. T. Parissis Estrogen administration in patients with chronic heart failure: not ready for prime time Eur J Heart Fail, March 1, 2003; 5(2): 113 - 116. [Full Text] [PDF]
|
|
|
|
 |
|
 K. L Moreau, A. J Donato, D. R Seals, C. A DeSouza, and H. Tanaka Regular exercise, hormone replacement therapy and the age-related decline in carotid arterial compliance in healthy women Cardiovasc Res, March 1, 2003; 57(3): 861 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L Moreau, A. J Donato, H. Tanaka, P. P. Jones, P. E Gates, and D. R Seals Basal leg blood flow in healthy women is related to age and hormone replacement therapy status J. Physiol., February 15, 2003; 547(1): 309 - 316. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Brown, D. R. Dengel, R. V. Hogikyan, and M. A. Supiano Sympathetic activity and the heterogenous blood pressure response to exercise training in hypertensives J Appl Physiol, April 1, 2002; 92(4): 1434 - 1442. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. K. Dubey, S. Oparil, B. Imthurn, and E. K. Jackson Sex hormones and hypertension Cardiovasc Res, February 15, 2002; 53(3): 688 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. W. Waters, M. G. Ziegler, and J. V. Meck Postspaceflight orthostatic hypotension occurs mostly in women and is predicted by low vascular resistance J Appl Physiol, February 1, 2002; 92(2): 586 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Dodt, H. L. Fehm, G. Weitz, W. Vongpatanasin, M. Tuncel, Y. Mansour, D. Arbique, R. G. Victor, B. E. Hunt, J. A. Taylor, et al. Effect of Estrogen Replacement Therapy on Sympathetic Activity in Postmenopausal Women Response Response Circulation, December 18, 2001; 104 (25): e161 - e162. [Full Text] [PDF]
|
|
|
|
|
|
X. Wang and A. A. Abdel-Rahman Estrogen modulation of eNOS activity and its association with caveolin-3 and calmodulin in rat hearts Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2309 - H2315. [Abstract] [Full Text] [PDF]
|
|